LICENSE AGREEMENTLicense Agreement • February 1st, 2024 • Redwoods Acquisition Corp. • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledFebruary 1st, 2024 Company Industry JurisdictionReliance Life Sciences Private Limited, a company incorporated under the laws of India, having its registered office at Dhirubhai Ambani Life Sciences Center, Thane - Belapur Road, Rabale, Navi Mumbai - 400 701, India, and its Affiliates (“RLS”)
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • February 1st, 2024 • Redwoods Acquisition Corp. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 1st, 2024 Company IndustryThis Sponsored Research Agreement (this “Agreement”), effective as of January 24, 2023 (“Effective Date”), is made and entered into by and between ANEW MEDICAL, INC. a private Delaware corporation having its principal offices at ANEW MEDICAL, INC., 13576 Walnut Street, Omaha, Nebraska 68144 USA (“Sponsor” or the “Company”)
LICENSE AGREEMENT ANDLicense Agreement • February 1st, 2024 • Redwoods Acquisition Corp. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 1st, 2024 Company IndustryUniversitat Autònoma de Barcelona (hereinafter, “UAB”), an institution organized as a university under the laws of Spain, with registered offices at Campus de la UAB, Plaza Cívica, s/n, 08193 Bellaterra, Spain, provided with Tax Identification number (CIF), Q-0818002-H, duly represented by Dr. Armando Sánchez Bonastre, acting in his capacity as Vice-rector for Research and Transfer of UAB, appointed by the Rector on November 13, 2020; and by virtue of the Resolution of November 23, 2020 for the present purposes and by virtue of the provisions of Article 75 of the Statutes of the UAB, approved by Decree 237/2003 of October 8, of the Generalitat de Catalunya;
LICENSE AGREEMENTLicense Agreement • February 1st, 2024 • Redwoods Acquisition Corp. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 1st, 2024 Company IndustryTHIS LICENSE AGREEMENT (the “Agreement”) is made and executed on this 27th day of January, 2023 (“Effective Date”) by and between (1) Anew Medical Acquisition Corp (“AMAC”) a Wyoming corporation with an address of 13576 Walnut Street, Omaha, NE 68144 USA (hereinafter referred to as “ANEW” or “the Company”) and Affiliates, successors and permitted assigns; and (2) TELEOST BIOPHARMACEUTICALS, LLC an Arizona Corporation, with principal place of business at 2500 Dartmouth Street, Boulder, CO 80305 USA (“TELEOST”). ANEW and TELEOST are individually referred to as a “Party” and jointly as “Parties”.
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • February 1st, 2024 • Redwoods Acquisition Corp. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 1st, 2024 Company IndustryThis Non-Exclusive License Agreement (this “Agreement”), is dated and effective as of 20 January, 2023 (the “Effective Date”), and is made and entered into between Heidelberg University, an institution of higher education having an address at Grabengasse 1, 69117 Heidelberg, Germany (“University”), and ANEW MEDICAL, Inc., having an address at 13576 Walnut Street, Omaha, NE, USA (“Company”) (independently “Party” and collectively the “Parties”).